Balance Sheet for GlaxoSmithKline PLC (GSK)

$ 37.23   0.14 (+0.38%) Volume: 3.64m 4:00 PM EST 25-Nov-2020
After Hours:  $ 37.33   0.10 (+0.27%) Volume: 12.63k 7:40 PM EST 25-Nov-2020
Statement: View:
Assets [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 6,242 4,934 5,180 6,042 8,592
Restrictable Cash - - - - -
Marketable Securities 105 107 105 110 111
Accounts Receivable 7,277 6,593 6,299 5,694 5,636
Loans Receivable - - - - -
Other Receivables 1,855 1,168 1,393 1,328 2,187
Receivables - - - - -
Inventories, Raw Materials 1,585 1,429 1,612 1,318 2,303
Inventories, Work in Progress 3,322 2,912 3,218 2,837 2,141
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 2,980 2,634 2,680 2,141 2,505
Inventories, Other 7,887 6,975 7,509 6,295 6,950
Inventories, Adjustments & Allowances - - - - -
Inventories 7,887 6,975 7,509 6,295 6,950
Prepaid Expenses 419 420 416 413 452
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 25,849 21,560 21,496 20,619 24,445
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment 15,995 15,968 15,880 13,862 15,879
Construction in Progress 2,528 2,726 3,380 3,909 3,935
Fixed Assets, Other 11,403 9,949 10,091 9,576 10,766
Fixed Assets, Total 29,926 28,643 29,350 27,347 30,580
Gross Fixed Assets 29,926 28,643 29,350 27,347 30,580
Accumulated Depreciation (14,921) (14,558) (14,674) (14,012) (16,332)
Net Fixed Assets 15,005 14,085 14,676 13,335 14,248
Intangibles 41,053 21,910 23,732 23,167 24,570
Cost in Excess 14,007 7,373 7,749 7,360 7,607
Non-Current Deferred Income Taxes 5,432 4,951 5,130 5,397 4,281
Other Non-Current Assets 1,353 2,007 1,909 1,479 1,459
Total Non-Current Assets 79,839 52,399 54,695 52,278 54,320
Total Assets 105,688 73,959 76,191 72,897 78,765
Liabilities [+] in Millions of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable (834) (1,229) (1,345) (1,610) (2,094)
Short Term Debt 9,175 7,379 3,818 5,095 1,928
Notes Payable - - - - -
Accrued Expenses - - - - -
Accrued Liabilities - - - - -
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 23,555 22,497 33,431 19,960 19,940
Total Current Liabilities 31,895 28,647 35,904 23,444 19,773
Long Term Debt 29,946 25,763 19,218 18,090 22,583
Deferred Income Tax 5,053 1,472 1,886 2,386 2,243
Other Non-Current Liabilities 13,109 13,343 14,409 22,853 21,082
Minority Interest 9,220 (139) 4,807 4,737 5,547
Capital Lease Obligations 1,339 56 58 51 69
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 58,667 40,496 40,378 48,066 51,455
Total Liabilities 90,562 69,143 76,282 71,510 71,228
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 15,125 4,816 (92) 1,387 7,537
Common Par 1,785 1,713 1,815 1,656 1,975
Additional Paid in Capital 4,209 3,937 4,080 3,645 4,172
Cumulative Translation Adjustments - - - - -
Retained Earnings 6,008 (3,459) (8,753) (6,653) (2,059)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 45,071 30,579 19,126 19,426 30,051
Total Equity 15,125 4,816 (92) 1,387 7,537
Total Liabilities & Shareholder's Equity 105,688 73,959 76,191 72,897 78,765
Cash Flow 6,986 5,153 2,931 1,310 12,338
Working Capital (6,046) (7,087) (14,408) (2,826) 4,672
Free Cash Flow 7,768 8,438 6,373 5,114 984
Invested Capital 45,071 30,579 19,126 19,426 30,051
Shares Outstanding - Common Class Only 2,495 2,482 2,479 2,455 2,435
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 6,617 6,323 6,700 6,058 7,177
Total Common Shares Outstanding 2,495 2,482 2,479 2,455 2,435
Treasury Shares 522 528 560 565 724
Basic Weighted Shares Outstanding 3,280 3,129 3,301 2,998 3,560
Diluted Weighted Shares Outstanding 3,326 3,166 3,339 3,028 3,602